2,983
Views
56
CrossRef citations to date
0
Altmetric
Short Communication

Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity

, , , , ORCID Icon, , & show all
Pages 831-839 | Received 31 Dec 2019, Accepted 10 Mar 2020, Published online: 25 Mar 2020

References

  • (a) de Torre MP, Cavero RY, Calvo MI, Vizmanos JL, A simple and a reliable method to quantify antioxidant activity in vivo. Antioxidants 2019;8:142. (b) Kundu T, Bhattacharjee B, Hazra S, et al. Synthesis and biological assessment of pyrrolobenzoxazine scaffold as a potent antioxidant. J Med Chem 2019;62:6315–29.
  • Habrant D, Poigny S, Ségur-Derai M, et al. Evaluation of antioxidant properties of monoaromatic derivatives of pulvinic acids. J Med Chem 2009;52:2454–64.
  • (a) Yanovsky I, Finkin-Groner E, Zaikin A, et al. Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer’s disease. J Med Chem 2012;55:10700–15. (b) Zhang C, Zhou Q, Wu XN, et al. Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease. J Enzym Inhib Med Chem 2019;34:260–70.
  • Hassan SZ, Gheita TA, Kenawy SA, et al. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis 2011;14:325–31.
  • Segovia J, Perez-Severiano F. Oxidative damage in Huntington’s disease. Methods Mol Biol 2004;277:321–34.
  • Secci D, Carradori S, Petzer A, et al. 4-(3-Nitrophenyl) thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis. J Enzym Inhib Med Chem 2019;34:597–612.
  • Signorelli SS, Scuto S, Marino E, et al. Oxidative stress in Peripheral Arterial Disease (PAD) mechanism and biomarkers. Antioxidants 2019;8:367.
  • Hao X, Qi G, Ma H, et al. Novel 2-phenoxypyrido [3, 2-b] pyrazin-3 (4 H)-one derivatives as potent and selective aldose reductase inhibitors with antioxidant activity. J Enzym Inhib Med Chem 2019;34:1368–72.
  • Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 2008;266:6–11.
  • Kakkar R. Isatin and its derivatives: a survey of recent syntheses, reactions, and applications. MedChemComm 2019;10:351–68.
  • Thanh ND, Giang NTK, Quyen TH, et al. Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2, 3, 4, 6-tetra-O-acetyl-β-d-glucopyranosyl) thiosemicarbazones. Eur J Med Chem 2016;123:532–43.
  • Eldehna WM, Al-Wabli RI, Almutairi MS, et al. Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents. J Enzym Inhib Med Chem 2018;33:867–78.
  • Eldehna WM, El Kerdawy AM, Al-Ansary GH, et al. Type IIA-Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amides. Eur J Med Chem 2019;163:37–53.
  • Abdel-Aziz HA, Eldehna WM, Keeton AB, et al. Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling. Drug Des Dev Ther 2017;11:2333–46.
  • Bindra JS. Oxindole alkaloids. In: Manske RHF, ed. The alkaloids. Vol 14. New York: Academic Press; 1973:84–121.
  • (a) Elderfield RC, Gilman RE. Alkaloids of Alstonia muelleriana. Phytochemistry 1972;11:339–43. (b) Ghedira K, Zeches-Hanrot M, Richard B, et al. Alkaloids of Alstonia angustifolia. Phytochemistry 1988;27:3955–62.
  • Jossang A, Jossang P, Hadi HA, et al. Horsfiline, an oxindole alkaloid from Horsfieldia superba. J Org Chem 1991;56:6527–30.
  • Anderton N, Cockrum PA, Colegate SM, et al. Oxindoles from Phalaris coerulescens. Phytochemistry 1998;48:437–9.
  • Sakai S, Aimi N, Yamaguchi K, et al. Gardneria alkaloids-IX structures of chitosenine and three other minor bases: from Gardneria multiflora makino. Tetrahedron Lett 1975;16:715–8.
  • M Heravi M, Zadsirjan V, Malmir M. Application of the asymmetric pictet–spengler reaction in the total synthesis of natural products and relevant biologically active compounds. Molecules 2018;23:943.
  • Cui C-B, Kakeya H, Osada H. Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase. Tetrahedron 1996;52:12651–66.
  • Kaur M, Singh B, Singh B, Arjuna A. Synthesis and evaluation of novel spiro [oxindole‐isoxazolidine] derivatives as potent antioxidants. J Heterocycl Chem 2017;54:1348–54.
  • Yu B, Yu D-Q, Liu H-M. Spirooxindoles: promising scaffolds for anticancer agents. Eur J Med Chem 2015;97:673–98.
  • Ibrahim HS, Eldehna WM, Fallacara AL, et al. One-pot synthesis of spiro (indoline-3, 4′-pyrazolo [3, 4-b] pyridine)-5′-carbonitriles as p53-MDM2 interaction inhibitors. Future Med Chem 2018;10:2771–89.
  • Eldehna WM, El-Naggar DH, Hamed AR, et al. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDAMB-231 cells. J Enzym Inhib Med Chem 2018;33:309–18.
  • Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271–7.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
  • Eldehna WM, Hassan GS, Al-Rashood ST, et al. Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)- 3-phenylureas as apoptosis-inducing agents. J Enzym Inhib Med Chem 2019;34:322–32.
  • El-Naggar M, Eldehna WM, Almahli H, et al. Novel thiazolidinone/thiazolo[3,2-a] benzimidazolone-isatin conjugates as apoptotic anti-proliferative agents towards breast cancer: one-pot synthesis and in vitro biological evaluation. Molecules 2018;23:1420.
  • Eldehna WM, Abo-Ashour MF, Ibrahim HS, et al. Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation. J Enzym Inhib Med Chem 2018;33:686–700.
  • Sabt A, Abdelhafez OM, El-Haggar RS, et al. Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies. J Enzym Inhib Med Chem 2018;33:1095–107.
  • Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. LWT-Food Sci Technol 1995;28:25–30.
  • Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay. Anal Biochem 1996;239:70–6.
  • Sordon S, Popłoński J, Milczarek M, et al. Structure–antioxidant–antiproliferative activity relationships of natural C7 and C7–C8 hydroxylated flavones and flavanones. Antioxidants 2019;8:210.
  • Stana A, Vodnar DC, Marc G, et al. Antioxidant activity and antibacterial evaluation of new thiazolin-4-one derivatives as potential tryptophanyl-tRNA synthetase inhibitors. J Enzym Inhib Med Chem 2019;34:898–908.
  • Swiss Institute of Bioinformatics. http://www.swissadme.ch/index.php.
  • Daina A, Zoete V. A boiled‐egg to predict gastrointestinal absorption and brain penetration of small molecules. Chem Med Chem 2016;11:1117–21.
  • Szakacs G, et al. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today 2008;13:379–93.
  • Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717.
  • Daina A, Michielin O, Zoete V. iLOGP: a simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach. J Chem Inf Model 2014;54:3284–301.
  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26.
  • Veber DF, Johnson SR, Cheng HY, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615–2623.
  • Egan WJ, Merz KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem 2000;43:3867–77.
  • Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1999;1:55–68.
  • Cheng T, Zhao Y, Li X, et al. Computation of octanol − water partition coefficients by guiding an additive model with knowledge. J Chem Inf Model 2007;47:2140–8.